Abnormal oxidative metabolism in a quiet genomic background underlies clear cell papillary renal cell carcinoma

Abstract
While genomic sequencing routinely identifies oncogenic alterations for the majority of cancers, many tumors harbor no discernable driver lesion. Here, we describe the exceptional molecular phenotype of a genomically quiet kidney tumor, clear cell papillary renal cell carcinoma (CCPAP). In spite of a largely wild-type nuclear genome, CCPAP tumors exhibit severe depletion of mitochondrial DNA (mtDNA) and RNA and high levels of oxidative stress, reflecting a shift away from respiratory metabolism. Moreover, CCPAP tumors exhibit a distinct metabolic phenotype uniquely characterized by accumulation of the sugar alcohol sorbitol. Immunohistochemical staining of primary CCPAP tumor specimens recapitulates both the depletion of mtDNA-encoded proteins and a lipid-depleted metabolic phenotype, suggesting that the cytoplasmic clarity in CCPAP is primarily related to the presence of glycogen. These results argue for non-genetic profiling as a tool for the study of cancers of unknown driver.
Funding Information
  • Damon Runyon Cancer Research Foundation (Dale F. Frey Award for Breakthrough Scientists, DFS-09-14)
  • V Foundation for Cancer Research (Junior Scholar Award, V2016-009)
  • Sidney Kimmel Foundation for Cancer Research (Kimmel Scholar Award, SKF-16-005)
  • National Institutes of Health (DK097153)
  • Charles Woodson Research Fund
  • The UM Pediatric Brain Tumor Initiative
  • University of Michigan (Program in Chemical Biology - Graduate Assistance in Areas of National Need (GAANN) award)
  • National Cancer Institute (P30 CA008748)
  • National Cancer Institute (P30 CA046592)
  • Sidney Kimmel Foundation for Cancer Research
  • American Urological Association (Research Scholar Award)